sars-cov-2

Documents about sars-cov-2

• Четвертое совещание Технической консультативной группы по вопросам безо- пасного обучения в школе в период пандемии COVID-19#144761WHO IRIS
• Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)#181711ClinicalTrials.gov
• NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants#253545Europe PMC
• PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS#311199ClinicalTrials.gov
• Impact of the COVID-19 pandemic on the selection of chest imaging modalities and reporting systems: a survey of Italian radiologists#445719IRIS
• Avaliação Integrada In Silico, In Vitro e In Vivo de Inibidores Baseados em Complexos Metálicos Direcionados à Protease Principal do SARS-CoV-2#483761RI UFPE
• Lean management of crisis response and post-pandemic outcomes in US primary care practices.#684039eScholarship
• Impact of (SARS-CoV-2) COVID 19 on the five main indigenous language-speaking areas in Veracruz Mexico: The case of the Otomi of the Ixhuatlan de Madero area#752594PhilArchive
• Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel#832050ClinicalTrials.gov
• Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms#832393ClinicalTrials.gov
• Evaluation of Peripheral Muscle With Ultrassonografic of Critical Patients With Covid-19#840620ClinicalTrials.gov
• Huashi Baidu Granule in the Treatment of Pediatric Patients With Mild Coronavirus Disease 2019#870552ClinicalTrials.gov
• Smell in Covid-19 and Efficacy of Nasal Theophylline#873808ClinicalTrials.gov
• Diagnosis of community-acquired pneumonia in children : South African Thoracic Society guidelines (part 2)#376595University of Pretoria Repository
• Acceptability of App-Based Contact Tracing for COVID-19: Cross-Country Survey Study#199608OpenAlex
• The right to data protection and the COVID-19 pandemic: the European approach#419056OpenAlex
• In the name of immunity, for the sake of the sacred: An analysis of the Iranian government's response to the COVID-19 outbreak.#136143PubMed
• Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients#156278HAL (France)
• Antiviral and Immunomodulatory Effects of Phytochemicals from Honey against COVID-19: Potential Mechanisms of Action and Future Directions#262294HAL (France)
• THE ROLE OF SELECTIVE MRNA DEADENYLATION IN THE HOMEOSTATIC CONTROL OF INNATE IMMUNE SIGNALING#263680ScholarlyCommons at Penn
• A cloth facemask increased ratings of perceived exertion and reduced affect, but did not affect sprint or muscular performance during training in athletes#487157SportRxiv
• Management of patients with lymphoma and COVID-19: Narrative review and evidence-based practical recommendations#644234IRIS
• Informe nº 93. Situación de COVID-19 en España a 25 de agosto de 2021.#646729Repisalud
• Determining the Safety and Efficacy of COVID-19 Vaccination in the Chronic Kidney Disease Population [CKD-COVID19, study data contributed to the CITF Databank]#657719Borealis Dataverse OAI Archive
• Comparative Analysis of Anti-COVID-19 (Severe Acute Respiratory Syndrome) Humoral and Memory T Cell Responses in Children With Various Degrees of Immunosuppression:#802286ClinicalTrials.gov
• Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Mild COVID-19#828861ClinicalTrials.gov
• Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination#839157ClinicalTrials.gov
• Assessing Immune Response of Different COVID-19 Vaccines in Older Adults#853054ClinicalTrials.gov
• A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age#857668ClinicalTrials.gov
• STEP-COVID: A Program for Pregnant Women During the SARS-CoV-2 Pandemic#866756ClinicalTrials.gov
• Clinical Trial of a Medical Device "Device for Non-invasive Electromagnetic Therapy "TOR" in the Treatment of COVID-19"#872675ClinicalTrials.gov
• COVID-19 Ozanimod Intervention Study#875400ClinicalTrials.gov
• Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity#877493ClinicalTrials.gov
• Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial#304184Europe PMC
• Social Network Analysis of COVID-19 Sentiments: Application of Artificial Intelligence#686398OpenAlex
• Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19#805730ClinicalTrials.gov
• Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study#6916OpenAlex
• Social determinants and factors associated with use of SARS-CoV-2 self-tests during the first months of self-test availability: findings from a population-based cohort study in France#18521Europe PMC
• Unveiling the burden of long covid in hospital and community settings: findings from the Post-Acute Sequelae of SARS-CoV-2 Network (PASCNET) cohort study in Italy's pandemic epicentre.#239674NCBI PubMed Central
• Synthesis, biological evaluation and molecular docking studies of flavonol-3-O-β-D-glycoside as a potential inhibitor of SARS-CoV-2 main protease (3CLpro) in drug development for COVID-19#413925Aperta
• SARS-CoV-2 infection and COVID-19 vaccination and the risk for new-onset type 1 diabetes: a register-based population study in Sweden#416626Springer Nature OA
• Functional Urban Areas in Poland in the context of the challenges of inner periphieries post SARS-CoV-2#473175RepOD Dataverse OAI Archive
• Vaccination Against COVID-19 in Chronic Kidney Disease#802268ClinicalTrials.gov
• Prospective, Multicenter Study Assessing a Screening Campaign for Cardiovascular Diseases Risk Factors During SARS-CoV-2 Epidemic#838636ClinicalTrials.gov
• A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)#841427ClinicalTrials.gov
• Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers#871931ClinicalTrials.gov
• Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection#439891S-Space: Seoul National University
• The IHI Rochester Report 2022 on Healthcare Informatics Research: Resuming After the CoViD-19#679210OpenAlex
• Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection#190637UNSWorks Repository
• The impact of COVID-19 vaccines on reinfection in Vietnam and Indonesia: the role of vaccine technology and dosage#191054Figshare